Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs WCC✓SelectedUSD · WCCGSK vs WCC performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs WCC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.1%
WCC return
+347.5%
Excess return
-250.4%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioWCCExcessAlpha
1D-0.1%-8.2%+8.1%+0.5%
7D-5.3%-12.4%+7.0%-4.3%
30D-3.7%-19.2%+15.5%-2.3%
3M-7.3%-16.5%+9.2%-6.4%
6M-4.2%-19.2%+14.9%-3.4%
YTD+0.9%+15.8%-15.0%-2.0%
1Y+7.3%+14.9%-7.7%+4.3%
3Y+52.7%+88.8%-36.1%+37.9%
5Y+40.1%+114.0%-73.9%+21.5%
All+97.1%+347.5%-250.4%+38.1%

Cumulative growth

Daily Returns

Daily percentage return beside WCC.

Daily Out/Under-Performance

Portfolio return minus WCC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × WCC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded WCC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling